Top
 

About Loeys-Dietz Syndrome

UNADJUSTEDNONRAW_thumb_9143.jpg

Loeys-Dietz syndrome (LDS) is a genetic disorder that affects the connective tissue in the body. The disorder was first observed and described by Dr. Bart Loeys and Dr. Hal Dietz at the Johns Hopkins University School of Medicine in 2005.

Characterized by significant manifestations, such as aortic aneurysms, arterial tortuosity, craniofacial and skeletal anomalies, LDS results from pathogenic variants in key genes of the transforming growth factor-beta signaling (TGFβ) pathway.


Have a question about Loeys-Dietz syndrome? Ask us!

Main Characteristics

Loeys-Dietz syndrome (LDS) can affect many parts of the body, including the arteries, heart, bones and joints, skin, eyes, and other organ systems. LDS can look very different from one person to another. A person may have many of the characteristics described below or only a few. Importantly, someone can have significant aortic or arterial disease even when outward physical features of LDS are subtle.

Some of the most recognizable features associated with LDS include aortic and arterial aneurysms, arterial tortuosity, widely spaced eyes (hypertelorism), and a broad or split (bifid) uvula. These findings can provide important clues to a diagnosis, but not everyone with LDS has these features, and they are not required to be present for someone to have LDS.

Because LDS affects connective tissue throughout the body, its characteristics are best understood by body system.

 
 
 
 

A Variable Condition

One of the most important things to understand about Loeys-Dietz syndrome is that there is no single LDS appearance or set of characteristics.

LDS is caused by genetic changes affecting the TGF-β signaling pathway. The genes associated with LDS include TGFBR1, TGFBR2, SMAD2, SMAD3, TGFB2, and TGFB3, as well as biallelic variants in IPO8, which cause a recessively inherited form within the LDS spectrum.

There is considerable overlap among the different genetic forms of LDS, but research has also identified differences in how frequently certain features occur and in the severity of some manifestations. Even people with the same genetic cause can have very different medical characteristics.

For this reason, the absence of characteristic facial, skeletal, skin, or other outward features does not exclude LDS or indicate that cardiovascular risk is absent.

An individual's care should be based on their specific genetic diagnosis, personal and family medical history, cardiovascular findings, and other manifestations.

What Does This Mean for Me?

The characteristics listed here represent features that have been observed in people with Loeys-Dietz syndrome. No individual with LDS should be expected to have all of them.

If you have LDS or are being evaluated for LDS, talk with a genetics professional and healthcare providers familiar with heritable connective-tissue and aortic conditions. They can help determine which findings and health considerations are relevant to you.

For more information about recommended evaluation, imaging, treatment, and ongoing care, see our Clinical Diagnosis and Treatment and Management resources.


LDSF_Pearl.jpg

Have a diagnosis and wondering what to do next? Check out our “Now What?” guide.

Diagnosis

Diagnosing Loeys-Dietz syndrome (LDS) involves looking at the whole person. Healthcare providers consider a combination of medical and family history, physical characteristics, cardiovascular and arterial findings, and genetic information.

Because LDS can vary widely from person to person—and some individuals have few outward signs—evaluation by healthcare professionals familiar with heritable connective tissue and aortic conditions is important.

LDSF_Light-Blue.jpg
 

Differential Diagnosis

Although Loeys-Dietz syndrome shows overlap with other disorders such as Marfan Syndrome (MFS), Ehlers-Danlos Syndrome (EDS), Shprintzen-Goldberg syndrome (SGS) and others, a variety of differential features set LDS apart from other disorders.

 
 

LDS and MARFAN SYNDROME

Individuals diagnosed with Marfan syndrome (MFS) exhibit several findings not found in LDS patients. These include:

  • ectopia lentis (dislocation of the lens of the eye)

  • dolichostenomelia (prominently long limbs)

Individuals with LDS tend to have a more translucent quality to their skin, allowing veins to be easily visible. Abnormal scarring and easy bruising also may occur to a greater degree in individuals with LDS.

Birth defects such as clubfoot, other structural heart defects and cleft palate (opening and obvious gap in the roof of the mouth) are also more likely to be associated with LDS.

It has also been discovered that the genetic cause for these two disorders is distinct. MFS is caused by a mutation (gene change) in the fibrillin-1 (FBN1) gene, while LDS is caused by a mutation the TGFBR1, TGFBR2, SMAD3, TGFB2, TGFB3 or SMAD2 gene.


LDS AND EHLERS-DANLOS SYNDROME

LDS is similar to vascular type Ehlers-Danlos (EDS) in that skin-related findings such as easy bruising, soft/velvety skin texture, wide scarring and translucent skin are seen in both syndromes. Both LDS and vascular type EDS have a relatively high instance of arterial aneurysms and, to a lesser degree, spontaneous organ rupture. Clubfoot may be observed in both disorders.

The disorders are different in that individuals with LDS have physical findings typically not present in individuals with vascular type EDS, such as widely-spaced eyes and bifid uvula.

Vascular type EDS occurs when the collagen an individual produces is not the appropriate quantity or quality. Genetic testing for a mutation in the COL3a1 gene or collagen biochemical studies performed on a skin biopsy sample can confirm this diagnosis. Individuals exhibiting EDS-like symptoms but who have had a normal test for vascular type EDS should be evaluated for LDS.


LDS AND SHPRINTZEN-GOLDBERG SYNDROME

Individuals with Shprintzen-Goldberg syndrome (SGS) and LDS may have similar findings, including craniosynostosis, pectus anomalies and scoliosis.

However, the vast majority of individuals with SGS do not show progressive or severe aneurysm formation of the aortic root or of other arteries. Another difference between these two disorders is that individuals with SGS are also more likely to show developmental delay. SGS is caused by mutations in the SKI gene.

Genetics and Inheritance

Loeys-Dietz syndrome is a genetic disorder that is caused by a mutation (gene change) in either the TGFBR1 or TGFBR2 genes (transforming growth factor beta receptor 1 or 2), the SMAD3 gene (mothers against decapentaplegic homolog 3), the TGFB2 gene (tgfbeta 2 or transforming growth factor beta 2 ligand) or the TGFB3 gene (tgfbeta 3 or transforming growth factor beta 3 ligand).

These genes encode for the receptors and other molecules involved in the tgf-beta pathway. Correlation between the genetic cause of LDS and physical manifestation continues to evolve (see gene association fact sheet).

 

There are SIX genetic causes of Loeys-Dietz syndrome, with the proposed naming system.

  • Loeys-Dietz syndrome 1 caused by mutations in the TGFBR1 gene

  • Loeys-Dietz syndrome 2 caused by mutations in the TGFBR2 gene

  • Loeys-Dietz syndrome 3 caused by mutations in the SMAD3 gene

  • Loeys-Dietz syndrome 4 caused by mutations in the TGFB2 gene

  • Loeys-Dietz syndrome 5 caused by mutations in the TGFB3 gene

  • Loeys-Dietz syndrome 6 caused by mutations in the SMAD2 gene

Although there is significant overlap between the clinical features caused by mutations in the different genes, we are learning about what might be differing features between the types and how this may impact medical management.

The term genetic disorder also indicates that the disorder has been present in an individual since conception. Loeys-Dietz syndrome exhibits an autosomal dominant inheritance pattern. This means that each offspring of an individual with LDS has a 50% chance of inheriting the gene mutation for LDS. There is no way to predict the severity of vascular, skeletal or skin findings that may occur in an offspring.

Many individuals are the first in their family to have the mutation causing LDS. These cases are caused by sporadic (random) mutations that occur during conception. There is no parental cause (medication or alcohol use for example) for the random mutation occurring. It is no one's fault.

For anyone who has the diagnosis of LDS and who is of reproductive age, it is recommended that they review the recurrence risk information with a genetics professional. There are testing options performed during pregnancy (prenatal diagnosis) and through in-vitro techniques (pre-implantation genetic diagnosis) to determine the presence of LDS in the fetus.

Have You Already Recieved a Genetic Test?

Understanding your genetic test results for conditions like Marfan, Loeys-Dietz, or VEDS can be challenging. Here’s a simple Q&A to help make sense of what your results may mean and what you might consider doing next.

LDSF_Light-Blue.jpg

Treatment & Management

There is no single treatment plan for Loeys-Dietz syndrome (LDS). Because LDS can affect many systems of the body—and because the type and severity of manifestations can vary considerably from person to person—care should be individualized.

The goals of LDS management are to identify and monitor cardiovascular and other complications, reduce the risk of aortic and arterial events, treat symptoms and other health concerns, and support long-term health and quality of life.

Management may involve specialists in cardiology, vascular and cardiovascular surgery, medical genetics, orthopedics, allergy and immunology, gastroenterology, pulmonology, ophthalmology, otolaryngology, rehabilitation medicine, maternal-fetal medicine, mental health, and other areas depending on an individual's needs.

An individual's care plan may be influenced by their genetic subtype, age, medical and family history, cardiovascular findings, rate of aortic growth, previous surgeries or vascular events, other LDS manifestations, and personal goals and preferences.

The latest LDS management recommendations emphasize multidisciplinary care and shared decision-making. People with LDS should work with healthcare professionals experienced in heritable aortic and connective tissue conditions whenever possible.

 

Cardiovascular & Arterial Surveillance

Regular cardiovascular and arterial imaging is a cornerstone of care for people with Loeys-Dietz syndrome (LDS). Because LDS can cause aneurysms, dissections, and arterial tortuosity throughout the body, surveillance includes both the aortic root and heart as well as the arterial system beyond the heart.

The type and frequency of imaging should be individualized. Factors such as a person's genetic subtype, age, family history, aortic and arterial measurements, rate of vessel growth, previous vascular events or surgery, and other cardiovascular findings may influence how often imaging is recommended.


Medications

Medications are commonly used in Loeys-Dietz syndrome (LDS) to reduce stress on the aorta and other arteries and to help slow the progression of aortic enlargement. Medication does not eliminate the risk of aneurysm or dissection and does not replace regular cardiovascular and arterial imaging.

The two primary classes of medications used for cardiovascular protection in LDS are angiotensin receptor blockers (ARBs) and beta-blockers. The choice of medication, dose, and whether more than one medication is used should be individualized based on a person's cardiovascular findings, blood pressure, heart rate, age, other medical conditions, and tolerance of treatment.

There is no single medication regimen that is appropriate for every person with LDS. Treatment decisions should take into account the individual's genetic subtype, cardiovascular findings, aortic growth, blood pressure and heart rate, other medical conditions, pregnancy considerations, medication tolerance, and previous vascular procedures or events.

Medication should be prescribed and adjusted in partnership with a healthcare professional familiar with LDS or other heritable aortic conditions. Individuals should not start, stop, or change cardiovascular medications without discussing the change with their healthcare team.

A Note About Other Medications

Some medications may require special consideration or may be avoided when appropriate alternatives are available for people with Loeys-Dietz syndrome. This does not mean these medications should not be used, but conversation and shared decision-making should be considered for their use.

See a table of medications that require careful consideration in the 2026 Updated Care Management Primer.


Aortic & Vascular Surgery

Surgery can play an important role in preventing life-threatening aortic and arterial complications in people with Loeys-Dietz syndrome (LDS). When an aneurysm reaches a size or shows other characteristics associated with increased risk, planned preventive surgery is generally safer than waiting for an aortic or arterial dissection or rupture to occur.

The timing and type of surgery should be individualized. Decisions may take into account the genetic subtype, size and location of the aneurysm, rate of growth, body size, age, family history, previous vascular events or surgery, heart valve function, other features associated with vascular risk, and pregnancy plans.

Whenever possible, people with LDS who require aortic or vascular surgery should be evaluated and treated at a center experienced in heritable aortic disease and complex aortic surgery.

Surgery Does Not End Vascular Surveillance

Aortic or vascular surgery repairs a specific portion of the arterial system, but it does not eliminate the underlying connective tissue condition.

People with LDS require lifelong cardiovascular and arterial surveillance after surgery because aneurysms, dissections, or other vascular changes can develop in portions of the aorta or arterial system that were not repaired.

Follow-up imaging is individualized according to the type of surgery, remaining vascular findings, genetic subtype, and the person's medical history.

An Evolving Area of LDS Care

New surgical technologies and techniques will continue to change the options available to people with LDS. Because experience with some newer approaches remains limited, decisions should consider both what is known about short-term outcomes and what is still uncertain about long-term durability in genetically altered aortic and arterial tissue.

Participation in shared decision-making with an experienced aortic team can help individuals understand how established and emerging approaches apply to their particular anatomy, genetic subtype, medical history, and treatment goals.


Physical Activity, Musculoskeletal & Bone Health

Loeys-Dietz syndrome can affect the bones, joints, muscles, and spine. Depending on a person's needs, care may involve orthopedics, physical or occupational therapy, rehabilitation medicine, or other specialists.


Allergy, Gastrointestinal & Pulmonary Care

Allergic, gastrointestinal, and respiratory conditions can occur with LDS. Evaluation and treatment should be based on each person's symptoms and needs.


Pain, Fatigue & Hypermobility

Pain, fatigue, and joint hypermobility can affect daily life for some people with LDS. Management should focus on maintaining comfort, function, strength, and participation in everyday activities.


Eyes, Hearing & Craniofacial Care

LDS can affect the eyes, hearing, teeth, palate, and development of the head and face. Appropriate evaluation and treatment can help address vision, hearing, dental, and functional concerns.


Mental Health & Emotional Well-Being

Living with Loeys-Dietz syndrome can bring uncertainty, ongoing medical appointments, imaging, surgeries, and concerns about future health. These experiences can affect emotional well-being and may contribute to anxiety, depression, or medical post-traumatic stress.

Mental health is an important part of overall LDS care. Individuals and families should feel comfortable discussing changes in mood, anxiety, stress, sleep, or coping with their healthcare team.

Counseling, therapy, support groups, and medication when appropriate can all be helpful. Connecting with others in the LDS community may also provide valuable support and understanding.


LDSF_Pearl.jpg

Emergency Situations

Most health concerns associated with Loeys-Dietz syndrome are managed through regular monitoring and medical care. However, certain complications can develop suddenly and require urgent medical attention.

Because LDS affects connective tissue throughout the body it is helpful for individuals with LDS, their families, and healthcare providers to be familiar with potential emergency situations.

These complications do not occur in everyone with LDS, and the level of risk varies from person to person and among genetic subtypes. Knowing that these emergency situations can occur helps individuals, families, and healthcare professionals recognize why appropriate surveillance and emergency preparedness are important.

Check out our Emergency Preparedness Kit and Emergency Alert Card to have on hand as a first source of information for First Responders.


 
 
 

Make a donation to support the Loeys-Dietz Syndrome Foundation.

LDSF_Blue.jpg